What is Microbot Medical's proceeds from legal settlements?

Microbot Medical (MBOT) reported proceeds from legal settlements of $316K in Q1 2025.

What does proceeds from legal settlements mean?

Measures the cash inflows received by the company as a result of favorable legal settlements or intellectual property disputes. This is a non-recurring item that can temporarily boost liquidity and cash flow positions.

Microbot Medical MBOT Proceeds From Legal Settlements

Proceeds From Legal Settlements at other companies

International Money ExpressIMXI

$821.5K—

Microbot MedicalMBOT

$316K—

BRCBRCC

$250K—

Saga CommunicationsSGA

$26.25K-93.1%

Avanos MedicalAVNS

$0—

ADMA BiologicsADMA

$400K—

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLegalSettlements.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's proceeds from legal settlements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's proceeds from legal settlements?: Microbot Medical (MBOT) reported proceeds from legal settlements of $316K in Q1 2025.
What does proceeds from legal settlements mean?: Measures the cash inflows received by the company as a result of favorable legal settlements or intellectual property disputes. This is a non-recurring item that can temporarily boost liquidity and cash flow positions.